These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22155411)

  • 1. Design of a pediatric oral formulation with a low proportion of hydrochlorothiazide.
    Santoveña A; Hernández-Paiz Z; Fariña JB
    Int J Pharm; 2012 Feb; 423(2):360-4. PubMed ID: 22155411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
    Kodym A; Wiśniewski A; Knioła D; Olejniczak M
    Acta Pol Pharm; 2011; 68(4):555-64. PubMed ID: 21796938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM; McDermott C; Barlow J; Ramtoola Z
    Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; Remon JP; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical and microbiological stability studies of extemporaneous antihypertensive pediatric suspensions for hospital use.
    Mendes C; Costa AP; Oliveira PR; Tagliari MP; Silva MA
    Pharm Dev Technol; 2013; 18(4):813-20. PubMed ID: 22670721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of ceftazidime in 1% and 5% buffered eye drops determined with HPLC method.
    Kodym A; Hapka-Zmich D; Gołab M; Gwizdala M
    Acta Pol Pharm; 2011; 68(1):99-107. PubMed ID: 21485707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
    Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
    J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and bioavailability assessment of ramipril nanoemulsion formulation.
    Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
    Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilazapril stability in the presence of hydrochlorothiazide in model mixtures and fixed dose combination.
    Paszun SK; Stanisz BJ; Gradowska A
    Acta Pol Pharm; 2013; 70(6):1079-85. PubMed ID: 24383331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of in situ novel intragastric controlled-release formulation of hydrochlorothiazide.
    Patel RR; Patel JK
    Acta Pharm; 2011 Mar; 61(1):73-82. PubMed ID: 21406345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method.
    Kodym A; Bilski P; Domańska A; Hełminiak Ł; Jabłońska M; Jachymska A
    Acta Pol Pharm; 2012; 69(1):95-105. PubMed ID: 22574512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and physicochemical stability studies of paediatric oral formulations of sildenafil.
    Provenza N; Calpena AC; Mallandrich M; Halbaut L; Clares B
    Int J Pharm; 2014 Jan; 460(1-2):234-9. PubMed ID: 24231050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of compounding and storage conditions on stability of pergolide mesylate.
    Davis JL; Kirk LM; Davidson GS; Papich MG
    J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
    Sosnowska K; Winnicka K; Czajkowska-Kośnik A
    Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability--A step closer from promising technology to application.
    Kasper JC; Schaffert D; Ogris M; Wagner E; Friess W
    J Control Release; 2011 May; 151(3):246-55. PubMed ID: 21223985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines.
    Pardeike J; Strohmeier DM; Schrödl N; Voura C; Gruber M; Khinast JG; Zimmer A
    Int J Pharm; 2011 Nov; 420(1):93-100. PubMed ID: 21889582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of pH modifiers on the dissolution and stability of hydrochlorothiazide in the bi- and three-layer tablets.
    Blatnik SU; Dreu R; Srčič S
    Acta Pharm; 2015 Dec; 65(4):383-97. PubMed ID: 26677896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound.
    Tong HH; Du Z; Wang GN; Chan HM; Chang Q; Lai LC; Chow AH; Zheng Y
    Int J Pharm; 2011 Feb; 404(1-2):148-58. PubMed ID: 21094233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation development and stability testing of oral morphine solution utilizing preformulation approach.
    Preechagoon D; Sumyai V; Tontisirin K; Aumpon S; Pongjanyakul T
    J Pharm Pharm Sci; 2005 Aug; 8(2):362-9. PubMed ID: 16124948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of new ophthalmic suspension prednisolone acetate 1%.
    Akram M; Shyum SB; Gauhar S
    Pak J Pharm Sci; 2010 Apr; 23(2):149-54. PubMed ID: 20363691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.